A novel paclitaxel-loaded poly(ε-caprola
✍
Yangqing Zhang; Lina Tang; Leilei Sun; Junbo Bao; Cunxian Song; Laiqiang Huang;
📂
Article
📅
2010
🏛
Elsevier Science
🌐
English
⚖ 562 KB
Multidrug resistance (MDR) of tumor cells is a major obstacle to the success of cancer chemotherapy. Poloxamers have been used in cancer therapy to overcome MDR. The objective of this research is to test the feasibility of paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 (PCL/Poloxamer 188